Literature DB >> 2413137

Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals.

J A Levy, J Shimabukuro.   

Abstract

Lymphocytopathic retroviruses have been recovered from the peripheral mononuclear cells of over 160 individuals in all segments of the population known to be at risk for developing AIDS. They have not been isolated from individuals coming from outside the risk groups. Virus has been cultured from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. Some of these AIDS-associated retroviruses (ARV) have been selected to be studied for differences in biologic and molecular features. The results support the role of this virus in AIDS and its associated diseases.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2413137     DOI： 10.1093/infdis/152.4.734

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  57 in total

1.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 2.  Scientific surveillance and the control of AIDS: a call for open debate.

Authors:  G T Stewart
Journal:  Health Care Anal       Date:  1994-11

3.  Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophages.

Authors:  Rajnish S Dave
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03

4.  CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.

Authors:  C E Mackewicz; H W Ortega; J A Levy
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.

Authors:  R Rooke; M A Parniak; M Tremblay; H Soudeyns; X G Li; Q Gao; X J Yao; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.

Authors:  A M Gómez; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

Authors:  B A Castro; C D Weiss; L D Wiviott; J A Levy
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.

Authors:  P Gupta; R Balachandran; M Ho; A Enrico; C Rinaldo
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Survival of human immunodeficiency virus (HIV), HIV-infected lymphocytes, and poliovirus in water.

Authors:  B E Moore
Journal:  Appl Environ Microbiol       Date:  1993-05       Impact factor: 4.792

10.  CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Authors:  M Scott Killian; Jeremy Roop; Sharon Ng; Frederick M Hecht; Jay A Levy
Journal:  J Clin Immunol       Date:  2009-02-03       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.